title: Sorafenib inhibits ABCG2 and overcomes irinotecan resistance--response.
authors.affiliation: Corresponding Author: Céline Gongora, IRCM INSERM U896, 208, rue des Apothicaires, 34298 Montpellier, France. celine.gongora@inserm.fr.
authors.forename: Céline
authors.initials: C
authors.lastname: Gongora
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000818:Animals; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage*
chemical_list: D018528:ATP-Binding Cassette Transporters; D009363:Neoplasm Proteins; D010671:Phenylurea Compounds; D009536:Niacinamide; D002166:Camptothecin